This march toward personalized, or precision, medicine for many disorders is being hastened by advances in diagnostic tools. They identified a significant fraction of patients whose tumors possess characteristics that indicate they can safely forgo chemo-and avoid its often serious side effects.
This year researchers took a step closer to even more personalized treatment. Many women whose tumors produce estrogen receptors, for instance, may receive drugs that specifically target those receptors, along with standard postsurgery chemotherapy. Therapy has since become more individualized: breast cancers are now divided into subtypes and treated accordingly. Mermec has also begun exporting the technology it has developed to other countries in the region such as India, the Philippines and Vietnam.For most of the 20th century all women with breast cancer received similar treatment. This includes installing Mermec technology on JR West’s Shinkansen high-speed trains. So we learned a lot and together with them we reached a level of performance which had never been reached worldwide.” “I want to say that we learned a lot from our Japanese customers, because they are demanding, but on the other hand, they are really best in class. “But afterwards we became a Japanese company with a very strong relationship with Italy, selling but also assisting our customers through the deployment and the service of the product.
“At the very beginning, we were Italians trying to sell something to Japan,” he says. Petrosillo says this has been fundamental to being able to do business in the Japanese market. Mermec approached the Japanese market 10 years ago, and set up a local subsidiary, Mermec Japan, in 2017. “It's a very nice match between measuring vehicles, rolling stock pantograph inspection systems, as well as a system for track inspection and measuring of track geometry.” “It has been a package of contracts which cover metro as well as conventional lines, and also a foreign country where we will jointly provide some measuring vehicles with Japanese technology,” he says. While names of the Japanese railway companies which signed the contracts were not released, Mermec vice president for international affairs, Mr Angelo Petrosillo, told IRJ they were “some of the most important Japanese railway administrators and private companies.” The contracts worth more than €20m were signed on May 27 at the Italian Embassy in Tokyo, in the presence of the Italian ambassador to Japan, Mr Gianluigi Benedetti, as well as representatives from Mitsubishi Electric, Sumitomo Corporation, Mitsui NCO, Hitachi Hitech, Japan International Cooperation Agency (JICA), and the Asian Development Bank (ADB). MERMEC, Italy, has signed three new contracts to provide advanced diagnostics for Japan’s rail and metro network.
0 kommentar(er)
